{"id":774,"date":"2023-12-22T08:11:15","date_gmt":"2023-12-22T08:11:15","guid":{"rendered":"https:\/\/greymatterpharma.com\/?page_id=774"},"modified":"2026-08-16T05:24:28","modified_gmt":"2026-08-16T04:24:28","slug":"reserached-pipelines","status":"publish","type":"page","link":"https:\/\/greymatterpharma.com\/index.php\/reserached-pipelines\/","title":{"rendered":"Reserached Pipelines"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Our Pipeline: Highlighting the Promising Drugs in Development<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

GM28K<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Treatment resistant depression (TRD)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

A novel approach to treating Treatment-Resistant Depression (TRD), aiming to improve lives and reduce dependency. GM28K represents a groundbreaking advancement in addressing TRD, offering new hope for those struggling with this challenging condition.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

GRE2811<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Treatment Of Alopecia<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Targeting Alopecia with groundbreaking pharmaceutical therapy. GRE2811 stands at the forefront of our efforts to address hair loss, offering a new dimension in the treatment landscape for individuals grappling with Alopecia.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

GM2813<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Gambling Disorder<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Innovative solutions for combating Gambling Disorder. GM2813 represents a dedicated initiative to address the complexities of Gambling Disorder, offering a ray of hope for those entangled in the grip of compulsive gambling.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

GM2814<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Mild Cognitive Impairment (MCI)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Addressing Mild Cognitive Impairment with advanced drug repurposing strategies. GM2814 symbolizes our commitment to enhancing cognitive health and function. By employing cutting-edge drug repurposing techniques,<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Our Innovative Research Pipeline<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our innovative research pipeline underscores our dedication to pioneering pharmaceutical solutions that make a difference in the lives of individuals facing various challenges. Through these promising drug developments, we aim to contribute to a healthier, more resilient future.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Researcher\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Have Questions? Get In Touch!<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tContact Us<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Our Pipeline: Highlighting the Promising Drugs in Development GM28K Treatment resistant depression (TRD) A novel approach to treating Treatment-Resistant Depression (TRD), aiming to improve lives and reduce dependency. GM28K represents a groundbreaking advancement in addressing TRD, offering new hope for those struggling with this challenging condition. GRE2811 Treatment Of Alopecia Targeting Alopecia with groundbreaking pharmaceutical therapy. GRE2811 stands at the…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_eb_attr":"","_templately_pack_id":"","_templately_imported_at":"","_templately_source":"","_templately_import_session_id":"","footnotes":""},"class_list":["post-774","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/pages\/774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/comments?post=774"}],"version-history":[{"count":27,"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/pages\/774\/revisions"}],"predecessor-version":[{"id":1125,"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/pages\/774\/revisions\/1125"}],"wp:attachment":[{"href":"https:\/\/greymatterpharma.com\/index.php\/wp-json\/wp\/v2\/media?parent=774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}